CNR1 rs1049353: Stress Response and Genetic Variation
The rs1049353 variant is a specific change within the CNR1 gene, which encodes the cannabinoid receptor 1. Research has investigated its potential associations with individual differences in stress responses, post-traumatic stress symptoms, and responses to certain antidepressant medications.
What each genotype means
Potential antidepressant resistance
Research suggests that individuals with this genotype may have an increased risk of antidepressant treatment resistance, particularly in the presence of comorbid anxiety. This variant is also studied for its potential role in how the brain processes social rewards and its interaction with childhood trauma in the context of stress-related symptoms. Please discuss any concerns regarding medication response or treatment plans with your clinician or pharmacist.
The specific frequency of this genotype is not widely established across all global populations.
Variable stress response profile
This genotype represents a heterozygous state for the rs1049353 variant, which has been investigated for its role in the endocannabinoid system's regulation of stress and emotional memory. Studies have linked this gene to individual differences in vulnerability to posttraumatic stress symptoms following childhood adversity. Because the evidence is limited and mixed, this information should not be used to predict personal health outcomes; consult a healthcare professional for medical guidance.
The specific frequency of this genotype is not widely established across all global populations.
Typical cannabinoid receptor variant
This genotype is the alternative variant (sometimes referred to as the A allele) of the rs1049353 polymorphism in the CNR1 gene. While the G allele has been more frequently associated with specific clinical observations regarding antidepressant response and stress sensitivity, the functional implications of the AA genotype remain a subject of ongoing research. As with all genetic findings, this result does not provide a diagnosis and should be discussed with a qualified medical provider.
The specific frequency of this genotype is not widely established across all global populations.
Understanding the rs1049353 Variant
The rs1049353 variant is a single nucleotide polymorphism (SNP) located within the CNR1 gene. In genetic research, this specific variant is often referred to as a synonymous G1359A change, meaning that while the DNA sequence is altered, it does not change the amino acid sequence of the resulting protein. Despite being synonymous, researchers study such variants to determine if they might influence gene expression, mRNA stability, or other regulatory processes. This SNP is situated on chromosome 6 and is one of many variations identified within the CNR1 gene that scientists examine to understand how genetic diversity might contribute to differences in human behavior and physiological responses to environmental stressors.
The Role of the CNR1 Gene
The CNR1 gene provides instructions for creating the cannabinoid receptor 1 protein. This receptor is a key component of the endocannabinoid system, a complex signaling network found throughout the central and peripheral nervous systems. Cannabinoid receptor 1 is primarily located at the terminals of neurons, where it helps regulate the release of various neurotransmitters. By modulating these signals, the receptor plays a significant role in processes such as mood regulation, memory, pain perception, and the body's response to stress. Because of its widespread influence on brain chemistry, variations in the CNR1 gene are frequently studied in the context of neuropsychiatric conditions, including depression, anxiety, and substance-related disorders.
Research Associations and Evidence Strength
Scientific literature has explored the potential links between rs1049353 and various psychiatric outcomes, though the evidence remains limited and requires further replication. Some studies have suggested that the G allele may be associated with an increased risk of antidepressant treatment resistance, particularly in female patients experiencing comorbid anxiety. Other research has investigated whether this variant interacts with childhood adversity to predict the development of post-traumatic stress symptoms. While these findings provide preliminary insights into how the endocannabinoid system might influence emotional processing and stress resilience, the associations are not definitive. Many of these studies involve relatively small sample sizes, and results have been mixed across different populations, highlighting the complexity of genetic influences on mental health.
Interpreting Your Genetic Information
It is important to understand that genetic variants like rs1049353 do not act in isolation; they interact with a wide array of environmental, social, and other genetic factors to shape an individual's health. Having a particular genotype does not mean an individual will develop a specific condition or respond to a medication in a certain way. If you are interested in how your genetics might relate to your health or medication response, it is essential to consult with a qualified healthcare provider or pharmacist. They can help you interpret your results within the context of your overall medical history and provide guidance on evidence-based care. Never use genetic information to make independent medical decisions or to alter prescribed treatments without professional supervision.
How common is this variant?
The population frequency for the rs1049353 variant is currently unknown, as comprehensive data across diverse global ancestries is not widely established in public databases.
Frequently asked questions
What does the CNR1 gene do?
The CNR1 gene encodes the cannabinoid receptor 1, which is part of the endocannabinoid system. This system helps regulate neurotransmitter release and is involved in mood, memory, and stress responses.
Is rs1049353 a diagnostic marker for PTSD?
No, rs1049353 is not a diagnostic marker. While some research has explored its association with stress-related symptoms, it cannot be used to diagnose PTSD or any other psychiatric condition.
Can this variant predict how I will respond to antidepressants?
Some preliminary research has looked at this variant in the context of antidepressant response. However, these findings are not conclusive, and you should always discuss medication management with your doctor.
Where can I find more information on this SNP?
You can search for rs1049353 on databases like the NCBI SNP database or the GWAS Catalog. These resources provide access to published research studies regarding the variant.
Sources & further reading
Educational information only, last refreshed 9/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1049353?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29